ModelEdge

BridgeBio Pharma Inc.
BBIO
Filing Type8-K
Filing Date7/1/2026
Updated7/2/26, 2:26 PM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-3.1EXHIBIT 3.1
EX-10.1EXHIBIT 10.1
EX-10.2EXHIBIT 10.2
EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
GRAPHIC
GRAPHIC
GRAPHIC